Gastroprotective strategies among NSAID users Guidelines for appropriate use in chronic illness (original) (raw)

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review

Lee Hooper

BMJ, 2004

View PDFchevron_right

The Relative Efficacies of Gastroprotective Strategies in Chronic Users of Nonsteroidal Anti-inflammatory Drugs

Colleen Metge

Gastroenterology, 2008

View PDFchevron_right

Gastroprotection during the administration of non-steroidal anti-inflammatory drugs. A drug-utilization study

Luis Arias

European Journal of Clinical Pharmacology, 2004

View PDFchevron_right

Are the clinical guideline recommendations on gastroprotection being followed? A review in patients taking nonsteroidal anti-inflammatory drugs

Luis Uscanga

Revista de Gastroenterología de México (English Edition), 2016

View PDFchevron_right

Recommendations for the appropriate use of anti-inflammatory drugs in the era of the coxibs: Defining the role of gastroprotective agents

D. Morgan, Ford Bursey

2000

View PDFchevron_right

A Very High Rate of Inappropriate Use of Gastroprotection for Nonsteroidal Anti-inflammatory Drug Therapy in Primary Care

Riccardo Marmo

Journal of Clinical Gastroenterology, 2011

View PDFchevron_right

Management of Gastroduodenopathy Associated With Use of Nonsteroidal Anti-Inflammatory Drugs

David Loeb

Mayo Clinic Proceedings, 1992

View PDFchevron_right

Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors

Angel Lanas

Drug, Healthcare and Patient Safety, 2009

View PDFchevron_right

Gastroprotection and Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Jeremy Hayllar

Drug Safety, 1992

View PDFchevron_right

Inappropriate Prevention of NSAID-Induced Gastrointestinal Events Among Long-Term Users in the Elderly

Angel Ferrández

Drugs & Aging, 2007

View PDFchevron_right

Canadian consensus guidelines on long‐term nonsteroidal anti‐inflammatory drug therapy and the need for gastroprotection: benefits versus risks

P. Moayyedi

Alimentary Pharmacology & Therapeutics, 2009

View PDFchevron_right

Use of NSAIDs, COX-2 inhibitors, and acetaminophen and associated coprescriptions of gastroprotective agents in an elderly population

Elham Rahme, Sheldon Kong

Arthritis & Rheumatism, 2002

View PDFchevron_right

Risk of Upper Gastrointestinal Complications Among Users of Traditional NSAIDs and COXIBs in the General Population

Alberto Rodriguez

Gastroenterology, 2007

View PDFchevron_right

Management of Patients on Nonsteroidal Anti-inflammatory Drugs: A Clinical Practice Recommendation From the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Antiplatelet Agents

Neena Abraham

American Journal of Gastroenterology, 2008

View PDFchevron_right

Panel discussion: treatment approaches to control gastrointestinal risk and balance cardiovascular risks and benefits: proposals and recommendations

Byron Cryer

Alimentary Pharmacology & Therapeutics Symposium Series, 2005

View PDFchevron_right

Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice

Ceri Phillips

BMC musculoskeletal disorders, 2006

View PDFchevron_right

Individual NSAIDs and Upper Gastrointestinal Complications

Miriam Sturkenboom

Drug Safety, 2012

View PDFchevron_right

Cardiovascular and gastrointestinal safety of NSAIDs

Eric Tjwa

Pharmaceutisch weekblad, 2014

View PDFchevron_right

Current Perspectives in NSAID-Induced Gastropathy

TEJ SINGH

Mediators of Inflammation, 2013

View PDFchevron_right

A review of the gastrointestinal safety data--a gastroenterologist's perspective

Angel Lanas

Rheumatology, 2010

View PDFchevron_right

Consensus about managing gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs?

Neville Yeomans

BMC Medicine, 2015

View PDFchevron_right

Risk of Peptic Ulcer Hospitalizations in Users of NSAIDs With Gastroprotective Cotherapy Versus Coxibs

Walter Smalley

Gastroenterology, 2007

View PDFchevron_right

NSAIDs: a clinical approach to the problems of gastrointestinal side-effects

Michael Hosokawa

Alimentary Pharmacology & Therapeutics, 2007

View PDFchevron_right

Non-Steroidal Anti-Inflammatory Drugs and Gastroprotection with Proton Pump Inhibitors

Antonio Gigante

Clinical Drug Investigation, 2012

View PDFchevron_right

Gastroprotection in NSAID and low-dose aspirin users: A cross-sectional study in primary care

Ma Josep Plazas

Gastroenterología y Hepatología, 2012

View PDFchevron_right

Use of gastrointestinal prophylaxis in NSAID patients: a cross sectional study in community pharmacies

ELSA LÓPEZ

International Journal of Clinical Pharmacy, 2011

View PDFchevron_right

Non-steroidal anti-inflammatory drugs and gastroprotection in primary health care users

Argjira Juniku-Shkololli

Medicine and Pharmacy Reports

View PDFchevron_right

Individual NSAIDs and Upper Gastrointestinal Complications A Systematic Review and Meta-Analysis of Observational Studies (the SOS Project

bod csongor

View PDFchevron_right

GASTROPROTECTIVE NSAIDs

Mohammad Shahnaz

Journal of Drug Delivery and Therapeutics, 2018

View PDFchevron_right

Usage Pattern of Gastroprotective Agents Among Patients Prescribed with NSAIDS in Orthopedics Department

Bharath raj

International Journal of Current Research and Review

View PDFchevron_right